Seeking Alpha August 10, 2020

Summary

CVS/Aetna is a true, one-of-a-kind “Health Innovation” business.

Tech is pushing it forward; Health and Consumer Goods keep bringing in the money.

Debt load is high, but income is far higher.

Considering how big tech has taken off like a rocket and powered everyone’s portfolio for the last five months or so, many folks should be looking at rotating to the market’s forgotten earners. While many may believe value investing is dead, it is possible to find names that have growth and value – and even better when they have a solid dividend. For folks who are looking for a company with all of these qualities in spades, look past Rite Aid...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech, Provider, Retail care
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales

Share This Article